Matthew P. Miller - 16 Dec 2022 Form 4 Insider Report for Oncology Institute, Inc. (TOI)

Role: Chief Operating Officer
Signature: By: Mark Hueppelsheuser For: Matt Miller
Issuer symbol: TOI
Transactions as of: 16 Dec 2022
Net transactions value: +$70,000
Form type: 4
Filing time: 20 Dec 2022, 19:07:11 UTC
Previous filing: 21 Nov 2022
Next filing: 21 Mar 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	TOI	Common Stock	Purchase	$70,000	+73,684	+72%	$0.9500	175,325	16 Dec 2022	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The purchase of common stock reported herein was matchable under Section 16(b) of the Securities Exchange Act of 1934, to the extent of 577 shares, with the reporting persons sale of shares of common stock on November 15, 2022. The reporting person has paid to the Issuer the full amount of the profit realized in connection with the short-swing transaction, less transaction costs, calculated in accordance with Section 16(b).

Content

The purchase of common stock reported herein was matchable under Section 16(b) of the Securities Exchange Act of 1934, to the extent of 577 shares, with the reporting persons sale of shares of common stock on November 15, 2022. The reporting person has paid to the Issuer the full amount of the profit realized in connection with the short-swing transaction, less transaction costs, calculated in accordance with Section 16(b).